You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complete pathological response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • CT/PET/WSI-based Deep Learning Signature
  • Zunyi, Guizhou, China
  • +2 more
Jun 27, 2023

Axillary Lymph Node Dissection, Pathological Complete Response, Neoadjuvant Systemic Therapy Trial in Nanjing (Stained region

Recruiting
  • Axillary Lymph Node Dissection
  • +4 more
  • Stained region Lymph Node Biopsy (SrLNB)
  • Regional lymph node radiotherapy (RNI) including the axilla
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Jul 10, 2023

Head and Neck Squamous Cell Carcinoma Trial in Zhuhai (dose-reduced radiotherapy)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • dose-reduced radiotherapy
  • Zhuhai, Guangdong, China
    Fifth Affiliated Hospital of Sun Yat-sen University
May 3, 2023

Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response

Recruiting
  • Refusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNB
  • Vacuum-assisted biopsy
  • Saint-Petersburg, Russian Federation
    Petr Krivorotko
Jun 14, 2022

Early Predict Pathological Complete Response to Neoadjuvant

Recruiting
  • Breast Cancer
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Aug 8, 2022

    Triple Negative Breast Tumors Trial (Xiaopi granules, Xiaopi decoction, Placebo)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • Xiaopi granules
    • +2 more
    • (no location specified)
    Nov 22, 2023

    Histology VABB-Histology Post Surgery Pilot Project

    Active, not recruiting
    • Breast Cancer
    • vacuum-assisted breast biopsy
    • Milan, Italy
      European Instituto of Oncology
    Oct 25, 2021

    Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in

    Active, not recruiting
    • Anatomic Stage IIIB Breast Cancer AJCC v8
    • +4 more
    • Pembrolizumab
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2022

    HER2-positive Breast Cancer Trial in Rome (PIK3CA analysis)

    Active, not recruiting
    • HER2-positive Breast Cancer
    • PIK3CA analysis
    • Rome, RM, Italy
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Feb 20, 2023

    Breast Cancer Trial in Ottawa (Trastuzumab)

    Recruiting
    • Breast Cancer
    • Ottawa, Ontario, Canada
      The Ottawa Hospital Cancer Centre
    Apr 26, 2022

    HER2-negative Breast Cancer, Neoadjuvant Therapy, Pathological Complete Response Trial in Beijing (Camrelizumab with vinorelbine

    Recruiting
    • HER2-negative Breast Cancer
    • +5 more
    • Camrelizumab with vinorelbine and cisplatin
    • Beijing, Beijing, China
      Peking University First Hospital
    Oct 15, 2022

    Breast Cancer Trial (Physical training)

    Not yet recruiting
    • Breast Cancer
    • Physical training
    • (no location specified)
    Jan 7, 2022

    Assessment Model of PCR After NAT on Breast Cancer AI Technology

    Recruiting
    • Breast Cancer
    • Neoadjuvant therapy
    • Beijing, Beijing, China
      National Cancer Center/National Clinical Research Center for Can
    Jun 30, 2022

    Prostate Cancer Trial in Canada (Abiraterone acetate with prednisone, Leuprolide, Cabazitaxel with peg-filgrastim)

    Completed
    • Prostate Cancer
    • Abiraterone acetate with prednisone
    • +2 more
    • Vancouver, British Columbia, Canada
    • +4 more
    Apr 13, 2022

    Fasting Mimicking Diet, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Netherlands (Fasting

    Not yet recruiting
    • Fasting Mimicking Diet
    • +5 more
    • Fasting Mimicking diet program
    • Alkmaar, Netherlands
    • +14 more
    Aug 15, 2022

    Breast Cancer Patients

    Completed
    • Neoadjuvant Chemotherapy
    • Neoadjuvant therapy
    • Istanbul, Turkey
      AcıbademAH
    Nov 21, 2023

    Breast Tumor, Neoadjuvant Therapy, Axillary Lymph Nodes Trial in Netherlands (RISAS)

    Completed
    • Breast Neoplasm
    • +3 more
    • RISAS
    • Assen, Netherlands
    • +13 more
    Feb 9, 2022

    Breast Cancer Trial in Angers, Saint-Herblain (Biopsy, Blood samples, Questionnaires)

    Not yet recruiting
    • Breast Cancer
    • Biopsy
    • +2 more
    • Angers, France
    • +1 more
    Jul 31, 2023

    Rectal Cancer Trial in Guangzhou (watch and wait)

    Recruiting
    • Rectal Cancer
    • watch and wait
    • Guangzhou, Guangdong, China
      Sun Yatsen University
    May 10, 2021

    Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • Positron emission tomography (PET)
    • +2 more
    • Birmingham, Alabama
    • +9 more
    Jan 20, 2023

    t Pathologic Complete Response Observed in HER2 Positive Breast

    Completed
    • HER2+ Breast Cancer
    • Rawalpindi, Punjab, Pakistan
      Rawalpindi Medical University
    Jun 26, 2023

    Breast Cancer Female, Chemo Effect Trial in Milano (MAMMOT2)

    Recruiting
    • Breast Cancer Female
    • Chemotherapy Effect
    • MAMMOT2
    • Milano, Italy
      Ospedale San Raffaele
    Feb 22, 2021

    Neoadjuvant Chemoradiotherapy, Locally Advanced Rectal Cancer, Pathological Complete Response Trial in Roma (RT Dose escalation

    Recruiting
    • Neoadjuvant Chemoradiotherapy
    • +2 more
    • RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT
    • Roma, Italy
      Fondazione Policlinico Universitario A.Gemelli IRCCS
    Mar 22, 2021

    After Neoadjuvant Using Excisional Biopsy By Radiofrequency In

    Terminated
    • Triple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients
      • Madrid, Spain
        Hospital General Universitario Gregorio Marañón
      Aug 7, 2020

      MRI Criterion After Neoadjuvant Therapy in Locally Advanced

      Completed
      • Rectal Neoplasms
        • Nîmes, Gard, France
          Chu de Nîmes
        Sep 8, 2022